Breakthrough Designation Rescissions: Who Might US FDA Drop Next?

 
• By Bridget Silverman

Our chart details the pipeline candidates who might lose the coveted status as treatment paradigms change and trial results come in.

Car rear view system monitor reverse video camera
Even if a development-stage product loses Breakthrough designation from the US FDA, it's regulatory progress isn't necessarily going in reverse.

More from Review Pathways

More from Pathways & Standards